Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascular AMD”

Showing 4 of 0 results

Not applicableStudy completedNCT05208931
What this trial is testing

Development of an Optimal Algorithm for the Management of Patients With Retinal Pigment Epithelium Detachment in Neovascular Age-related Macular Degeneration Using Artificial Intelligence

Who this might be right for
Neovascular Age-related Macular Degeneration
The S.N. Fyodorov Eye Microsurgery State Institution 300
Early research (Phase 1)Study completedNCT02204683
What this trial is testing

Pharmacokinetic Study of Intravitreal Aflibercept Injection in Eyes With Wet Age-related Macular Degeneration

Who this might be right for
Neovascular Macular Degeneration
University of Nebraska 5
Testing effectiveness (Phase 2)UnknownNCT00331253
What this trial is testing

Treatment of Patients With Neovascular AMD Using Indocyanine Green-Mediated Photothrombosis (i-MP).

Who this might be right for
Maculopathy, Age-Related
Opto Eletronica S.A. 280
Not applicableNot Yet RecruitingNCT07761039
What this trial is testing

Real-World Study of Intravitreal Aflibercept 8 mg in Pretreated Eyes With nAMD or DME

Who this might be right for
nAMDDME
Grupo de Estudos da Retina 100

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation